<?xml version="1.0" encoding="UTF-8"?>
<p>All of the recent changes to increase access to treatment and reduce incarceration that have been enacted during the COVID-19 crisis should persist not just for the duration of that emergency but in perpetuity. There is no evidence that requiring individuals to visit a methadone clinic most mornings improves outcomes, and a great deal of evidence that it reduces access to that lifesaving treatment.
 <sup>
  <xref rid="R14" ref-type="bibr">14</xref>
 </sup> Likewise, there is little reason to require an in-person evaluation for buprenorphine initiation, particularly in light of the impact of the opioid crisis on rural America, where waivered providers are few and far between.
 <sup>
  <xref rid="R15" ref-type="bibr">15</xref>
 </sup> There is neither reason to jail most people awaiting trial nor to incarcerate people for low-level crimes, many of which are related to lack of access to substance use disorder treatment or other mental health services.
</p>
